5 states are set to vote on marijuana legalization. Here’s everything you need to know.

Voters in New Jersey, Arizona, South Dakota, and Montana are set to weigh in on legalizing cannabis for all adults over the age of 21. South Dakota also has a medical-cannabis measure on the ballot. Mississippi voters will decide on whether to implement a medical-marijuana program.

We’ve put together a comprehensive tracker to explain the ballot measures and assign probabilities to each one’s passing. It’s available exclusively to Business Insider subscribers.

The ultimate guide to marijuana legalization: All the states voting on cannabis reform in November, the probability of success, and which stocks could benefit the most
Marijuana is legal for adults in 11 states and Washington, DC. Medical marijuana is legal in 33. Here’s the map:

All the states where marijuana is legal — and 4 more that could legalize it in November
How to invest in the industry
Cannabis stocks soared after Sen. Kamala Harris said at the vice-presidential debate that a Biden administration would decriminalize marijuana at the federal level. Curaleaf, Harvest Health and Recreation, and Aphria were among the top gainers, though the entire sector seems to have been energized by Harris’ statement.

Wall Street analysts say a Democratic sweep in November that puts presidential nominee Joe Biden in the White House and the party in control of the Senate could be a boon for cannabis stocks.

Analysts at CIBC and Cowen picked seven stocks to bet on that would benefit investors if the Democrats win, including Green Thumb Industries, Curaleaf, and Canopy Growth.

Top Wall Street analysts say these are the 7 cannabis stocks to bet on now that will benefit investors if Biden defeats Trump in November
Cowen analyst Vivien Azer said that if New Jersey voters chose to legalize the drug, it could push neighboring states like New York, Pennsylvania, Connecticut, and Rhode Island to do the same. That would mean huge wins for the cannabis giants Curaleaf, Green Thumb Industries, Acreage Holdings, Cresco Labs, and MedMen.

Curaleaf, which has operations in three of the four states Azer predicted would follow New Jersey’s lead, stands to benefit the most.

Here are the top 5 cannabis stocks to buy now to profit from a $6 billion wave of cannabis legalization across the Northeast, according to a top Wall Street analyst
The bigger populations in Arizona and New Jersey “represent a far greater revenue opportunity” for the cannabis firms Curaleaf, GTI, Acreage Holdings, and Cresco Labs, which are all well-positioned to benefit from legalization, Azer said.

Adult-use marijuana is on the ballot in 4 states, and a top Wall Street analyst lays out which cannabis stocks could get the biggest boost from legalization
What it all means for executives, investors, consumers, and voters
We spoke to top execs at 7 of the biggest US cannabis companies, and they said the industry is headed for a rebound, M&A is set to ramp up, and a Democratic win in November could be ‘jet fuel’ for the sector
US cannabis companies posted strong earnings as the coronavirus pandemic boosted sales in the second quarter. We spoke with executives at seven of the biggest US cannabis companies to understand what’s in store for the industry after a disappointing 2019 and a challenging start to 2020.

They predicted that a Biden win — and Democratic control of the Senate — would pour “jet fuel” on the industry.

3 cannabis execs share how they’re positioning their firms to profit as more US states are poised to legalize recreational marijuana
Voters in Arizona, Montana, New Jersey, and South Dakota will decide whether to legalize adult-use cannabis in November. We talked to CEOs at three cannabis companies who shared how they planned to profit amid the cannabis market’s expected growth in the coming years.

Companies like Miss Grass and Frigg, which are focused on building up consumer brands, say that as more states legalize cannabis, building up a national brand will be key to winning a major stake in the market.

Jeremy Berke Oct 28, 2020
Source: Business Insider

FDA DISCLAIMER- These statements and products referred to throughout this site have not been evaluated by the FDA. These products are not evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. These products are not for use by or for sale to persons under the age of 18. These products should not be used if you are pregnant or nursing. Consult with a healthcare professional before use if you have a serious medical condition or use prescription medications. A doctors advice should be sought before using this and any supplemental dietary product.

Get Updates And Stay Connected
Subscribe To Our Newsletter

Feel better. Live better.

Founded with advanced research and development plus ancient Mayan healing rituals in mind – Qtopix is where medicine meets nature.


Contact Us

Follow Us

©2022 Qtopix. All Rights Reserved.